$0.40
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NYSEAM:AIM
AIM ImmunoTech Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2014 | 2013 | 2012 | 2011 | 2010 | 2007 | 2006 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.20M | $0.14M | $0.14M | $0.16M | $0.14M | $0.37M | $0.20M | $0.15M | $0.21M | $0.16M | $0.14M | $1.06M | $0.93M | $1.23M | |
| GM % | Gross Margin % |
|
79.21% | 100.00% | 0.00% | 0.00% | 0.00% | -140.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 12.18% | -36.66% | -71.85% | |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.63 | $-0.37 | $-0.36 | $-0.49 | $-3.51 | $-9.89 | $-48.53 | $-48.68 | $-63.36 | $-36.96 | $-52.80 | $-132.00 | $-163.68 | $-110.88 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
49.1m | 48.08m | 47.99m | 42.15m | 10.39m | 1.11m | 0.39m | 0.32m | 0.32m | 0.26m | 0.26m | 0.14m | 0.13m | 0.09m | |
| OCF | Operating Cash Flow |
|
$-21.27M | $-16.11M | $-13.97M | $-10.37M | $-9.07M | $-10.64M | $-13.96M | $-16.90M | $-13.14M | $-10.10M | $-11.89M | $-15.11M | $-13.75M | $-7.24M | |
| FCF | Free Cash Flow |
|
$-22.00M | $-16.20M | $-14.01M | $-10.39M | $-9.14M | $-10.69M | $-14.46M | $-17.80M | $-18.90M | $-11.90M | $-12.62M | $-15.32M | $-15.10M | $-7.39M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.45 | $-0.34 | $-0.31 | $-0.34 | $-2.59 | $-10.72 | $-41.29 | $-56.93 | $-71.52 | $-47.30 | $-51.03 | $-114.18 | $-129.58 | $-88.80 |
